Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Forum on Immunopathological Diseases and Therapeutics
SJR: 0.309 SNIP: 0.041 CiteScore™: 0.18

ISSN Imprimir: 2151-8017
ISSN On-line: 2151-8025

Archives: Volume 1, 2010 to Volume 7, 2016

Forum on Immunopathological Diseases and Therapeutics

DOI: 10.1615/ForumImmunDisTher.2015014073
pages 7-23

CD20 and Its Antibodies: Past, Present, and Future

Robert J. Oldham
The Antibody and Vaccine Group, Cancer Sciences Unit, University of Southampton, Faculty of Medicine, General Hospital, Southampton, SO16 6YD, UK.
Kirstie L.S. Cleary
The Antibody and Vaccine Group, Cancer Sciences Unit, University of Southampton, Faculty of Medicine, General Hospital, Southampton, SO16 6YD, UK.
Mark S. Cragg
The Antibody and Vaccine Group, Cancer Sciences Unit, University of Southampton, Faculty of Medicine, General Hospital, Southampton, SO16 6YD, UK.

RESUMO

The pan B-cell marker CD20 was cloned more than 3 decades ago. It has been intensively studied ever since, allowing the specific identification and targeting of B cells facilitating the development of antibody-mediated immunotherapy. In this review, we document the current understanding of how CD20 regulates B-cell biology. We also describe the emerging knowledge of how anti-CD20 antibodies elicit their therapeutic responses, revealing how this has changed and matured throughout the decades of their use.

Palavras-chave: ADCC, ADCP, CD20, FcγR, lymphoma, Rituxan, rituximab

Articles with similar content:

Structure and Function of the Immune Semaphorin CD100/SEMA4D
Critical Reviews™ in Immunology, Vol.23, 2003, issue 1-2
Abdellah Elhabazi, Armand Bensussan, Laurence Boumsell, Isabelle Chabbert-de Ponnat, Anne Marie-Cardine
Targeting the Human Kinome for Cancer Therapy: Current Perspectives
Critical Reviews™ in Oncogenesis, Vol.17, 2012, issue 2
Luxi Zhang , Roger J. Daly
Dendritic Cell-Derived Exosomes as Cell-Free Peptide-Based Vaccines
Critical Reviews™ in Immunology, Vol.25, 2005, issue 3
Julien Taieb, Nathalie Chaput, Laurence Zitvogel
Immunopotentiating and Immunotherapeutic Effects of Thymic Hormones and Factors with Special Emphasis on Thymic Humoral Factor THF-γ2
Critical Reviews™ in Immunology, Vol.19, 1999, issue 4
Yona Keisari, Yigal Burstein, Shlomo Ben-Efraim, Rachel Ophir, Marit Pecht, Nathan Trainin
Regulation of Lymphoid Cell Apoptosis by Jaks and Stats
Critical Reviews™ in Immunology, Vol.24, 2004, issue 2
Zsuzsanna S. Nagy, Jeremy Ross, Robert A. Kirken, Stanislaw M. Stepkowski, Hanyin Cheng